Ew Healthcare Partners Fund 2, L.P. 的 Form 4/A 修正申報
修正TELA Bio, Inc.（TELA），2021/9/20 申報
- 申報編號
- 0000899243-21-036633
- 申報時間
- 2021/9/20 18:31 ET
- 交易日
- 2021/9/15
- 申報延遲
- 5 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2021/9/17
這份申報列了 1 筆非衍生性交易。公開市場買進合計 $12.4 萬。交易後 5 天申報。
這份修正申報取代了 0000899243-21-036434（2021/9/17 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Ew Healthcare Partners Fund 2, L.P.CIK 0001746777 | 其他：See footnote 2 |
| Ew Healthcare Partners Fund 2-A, L.P.CIK 0001746779 | 其他：See footnote 2 |
| EW Healthcare Partners Fund 2 GP, L.P.CIK 0001793943 | 持股 10% 以上大股東 |
| EW Healthcare Partners Fund 2-UGP, LLCCIK 0001793948 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/9/15 | Common Stock, par value $0.001 per share | P買進取得 | +10,000 | $12.43 | +$124,300 | 1,832,048 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 4,045 shares of the amount shown above and Fund 2-A purchased 5,955 shares of the amount shown above. Fund 2 now holds a total of 761,160 shares and Fund 2-A now holds a total of 1,070,888 shares of the Issuer.
- F2
EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.
- F3
This Amended Form 4 is filed only to correct the date set forth in the original Form 4 filed on September 17, 2021. No other change has been made to the original Form 4 filed on September 17, 2021 relating to the trade made on September 15, 2021.